However, our current data suggest that the large increase in SOD2 levels measured by ELISA both in vitro (in tumor cells) and in vivo (on BC patients) would originate mostly from the mitochondrial form liberated upon cell death rather than from secretion. The gene discussed is SOD2; the disease is breast cancer.